PO-1211: Stereotactic radiotherapy combined with immune- or targeted therapy for renal cell cancer patients. (November 2020) - Kroeze, S.; Fritz, C.; Siva, S.; Kahl, K.H.; Sundahl, N.; Blanck, O.; Kaul, D.; Grosu, A.L.; Verhoeff, J.J.C.; Skazikis, G.; Roeder, F.; Geier, M.; et al.